Agilent Technologies, Inc. Website

Agilent Technologies, Inc.

NYSE-A

Basic

  • Market Cap

    $39.38B

  • EV

    $40.44B

  • Shares Out

    291.76M

  • Revenue

    $6,591M

  • Employees

    17,600

Margins

  • Gross

    50.63%

  • EBITDA

    24.46%

  • Operating

    20.54%

  • Pre-Tax

    20.16%

  • Net

    18.84%

  • FCF

    23.33%

Returns (5Yr Avg)

  • ROA

    10.69%

  • ROTA

    24.9%

  • ROE

    20.91%

  • ROCE

    15.86%

  • ROIC

    15.45%

Valuation (TTM)

  • P/E

    —

  • P/B

    —

  • EV/Sales

    —

  • EV/EBITDA

    —

  • P/FCF

    —

  • EV/Gross Profit

    —

Valuation (NTM)

  • Price Target

    $141.35

  • P/E

    —

  • PEG

    —

  • EV/Sales

    —

  • EV/EBITDA

    —

  • P/FCF

    —

Financial Health

  • Cash

    $1,671M

  • Net Debt

    $1,055M

  • Debt/Equity

    0.44

  • EBIT/Interest

    15.39

Growth (CAGR)

  • Rev 3Yr

    4.25%

  • Rev 5Yr

    5.6%

  • Rev 10Yr

    2.08%

  • Dil EPS 3Yr

    12.16%

  • Dil EPS 5Yr

    4.15%

  • Dil EPS 10Yr

    7.15%

  • Rev Fwd 2Yr

    0.04%

  • EBITDA Fwd 2Yr

    3.5%

  • EPS Fwd 2Yr

    2.85%

  • EPS LT Growth Est

    5.01%

Dividends

  • Yield

    —

  • Payout

    21.71%

  • DPS

    $0.92

  • DPS Growth 3Yr

    7.22%

  • DPS Growth 5Yr

    8.05%

  • DPS Growth 10Yr

    6.23%

  • DPS Growth Fwd 2Yr

    6.76%

Select a metric from the list below to chart it

Oct '14

Oct '15

Oct '16

Oct '17

Oct '18

Oct '19

Oct '20

Oct '21

Oct '22

Oct '23

LTM

Oct '24 (E)

Oct '25 (E)

Oct '26 (E)

Metric
Oct '14
Oct '15
Oct '16
Oct '17
Oct '18
Oct '19
Oct '20
Oct '21
Oct '22
Oct '23
LTM

Total Revenues

5,163

5,339

6,319

6,848

6,833

6,591

Total Revenues % Chg.

5.1%

3.4%

18.4%

8.4%

-0.2%

-6.4%

Cost of Goods Sold, Total

2,358

2,502

2,912

3,126

3,368

3,254

Gross Profit

2,805

2,837

3,407

3,722

3,465

3,337

Selling General & Admin Expenses, Total

1,358

1,395

1,562

1,578

1,578

1,518

R&D Expenses

404

397

441

467

481

465

Other Operating Expenses, Total

1,762

1,792

2,003

2,045

2,059

1,983

Operating Income

1,043

1,045

1,404

1,677

1,406

1,354

Interest Expense, Total

-74

-78

-81

-84

-95

-88

Interest And Investment Income

36

8

2

9

51

67

Net Interest Expenses

-38

-70

-79

-75

-44

-21

Income (Loss) On Equity Invest.

—

—

—

—

—

—

—

—

Currency Exchange Gains (Loss)

-7

-4

-4

-6

-2

5

Other Non Operating Income (Expenses)

18

14

15

14

62

66

EBT, Excl. Unusual Items

1,016

985

1,336

1,610

1,422

1,404

Restructuring Charges

—

—

-44

-151

-37

-30

-25

-23

Merger & Related Restructuring Charges

—

—

—

-48

-41

-41

-25

-16

-16

Gain (Loss) On Sale Of Investments

—

—

—

—

4

27

98

-67

-41

-30

Asset Writedown

—

—

—

—

—

—

—

—

—

In Process R&D Expenses

—

—

—

—

—

—

—

—

—

—

-6

Legal Settlements

—

—

—

—

—

—

22

—

—

—

—

Other Unusual Items

—

—

—

-9

—

4

16

-1

—

EBT, Incl. Unusual Items

919

842

1,360

1,504

1,339

1,329

Income Tax Expense

-152

123

150

250

99

87

Earnings From Continuing Operations

1,071

719

1,210

1,254

1,240

1,242

Earnings Of Discontinued Operations

—

—

—

—

—

—

—

—

—

Net Income

1,071

719

1,210

1,254

1,240

1,242

Net Income to Common Incl Extra Items

1,071

719

1,210

1,254

1,240

1,242

Net Income to Common Excl. Extra Items

1,071

719

1,210

1,254

1,240

1,242

Total Shares Outstanding

309.1

306.2

302.2

295.3

292.1

291.6

Weighted Avg. Shares Outstanding

314

309

304

299

294

292.5

Weighted Avg. Shares Outstanding Dil

318

312

307

300

296

294.5

EPS

3.4

2.3

4

4.2

4.2

4.2

EPS Diluted

3.4

2.3

3.9

4.2

4.2

4.2

EBITDA

1,281

1,353

1,725

1,994

1,677

1,612

Effective Tax Rate

-16.5%

14.6%

11%

16.6%

7.4%

6.5%